Related references
Note: Only part of the references are listed.Genome Sequencing during a Patient's Journey through Cancer
Jyoti Nangalia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors
Rashmi S. Goswami et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
High-Throughput Microdissection for Next-Generation Sequencing
Avi Z. Rosenberg et al.
PLOS ONE (2016)
Digitally guided microdissection aids somatic mutation detection in difficult to dissect tumors
Katherine Geiersbach et al.
CANCER GENETICS (2016)
Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours
R. R. Singh et al.
BRITISH JOURNAL OF CANCER (2014)
The estimation of tumor cell percentage for molecular testing by pathologists is not accurate
Alexander J. J. Smits et al.
MODERN PATHOLOGY (2014)
A Prospective, Multi-Institutional Diagnostic Trial to Determine Pathologist Accuracy in Estimation of Percentage of Malignant Cells
Hollis Viray et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
Xiaoqing Liu et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group study BR.21
Chang-Qi Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening
PA Jänne et al.
CLINICAL CANCER RESEARCH (2006)
Share Paper
